BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26965446)

  • 1. The impact and optimal indication of non-curative gastric resection for stage IV advanced gastric cancer diagnosed during surgery: 10 years of experience at a single institute.
    Yamada N; Akai A; Nomura Y; Tanaka N
    World J Surg Oncol; 2016 Mar; 14():79. PubMed ID: 26965446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative.
    Jin LX; Moses LE; Squires MH; Poultsides GA; Votanopoulos K; Weber SM; Bloomston M; Pawlik TM; Hawkins WG; Linehan DC; Strasberg SM; Schmidt C; Worhunsky DJ; Acher AW; Cardona K; Cho CS; Kooby DA; Levine E; Winslow ER; Saunders ND; Spolverato G; Maithel SK; Fields RC
    Ann Surg; 2015 Dec; 262(6):999-1005. PubMed ID: 25607760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The patterns and timing of recurrence after curative resection for gastric cancer in China.
    Liu D; Lu M; Li J; Yang Z; Feng Q; Zhou M; Zhang Z; Shen L
    World J Surg Oncol; 2016 Dec; 14(1):305. PubMed ID: 27931221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer.
    Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Terashima M
    Ann Surg Oncol; 2013 May; 20(5):1575-83. PubMed ID: 23076557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T
    Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of non-curative gastrectomy for incurable gastric carcinoma.
    Jeong O; Park YK; Choi WY; Ryu SY
    Ann Surg Oncol; 2014 Aug; 21(8):2587-93. PubMed ID: 24633671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of immunochemo-surgery for gastric carcinoma.
    Kim JP; Yu HJ; Lee JH
    Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China.
    Deng J; Liang H; Sun D; Wang D; Pan Y
    Ann Surg Oncol; 2010 May; 17(5):1259-66. PubMed ID: 20217252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study.
    Pacelli F; Cusumano G; Rosa F; Marrelli D; Dicosmo M; Cipollari C; Marchet A; Scaringi S; Rausei S; di Leo A; Roviello F; de Manzoni G; Nitti D; Tonelli F; Doglietto GB;
    JAMA Surg; 2013 Apr; 148(4):353-60. PubMed ID: 23715879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer.
    Kim ER; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ; Kim KM; Kim S
    Br J Surg; 2015 Oct; 102(11):1394-401. PubMed ID: 26313295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
    Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
    J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
    Saito M; Kiyozaki H; Takata O; Suzuki K; Rikiyama T
    World J Surg Oncol; 2014 Dec; 12():406. PubMed ID: 25551581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncurative Resection for Gastric Cancer Patients: Who Could Benefit? : Determining Prognostic Factors for Patient Selection.
    Coimbra FJ; da Costa WL; Ribeiro HS; Diniz AL; de Godoy AL; de Farias IC; Filho AM; Fanelli MF; Begnami MD; Soares FA
    Ann Surg Oncol; 2016 Apr; 23(4):1212-9. PubMed ID: 26542593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis.
    Son T; Hyung WJ; Kim JW; Kim HI; An JY; Cheong JH; Choi SH; Noh SH
    Ann Surg Oncol; 2014 Mar; 21(3):899-907. PubMed ID: 24276641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.